Vivani Medical, Inc. SEC filings VANI

Vivani Medical, Inc. has 838 filings in SEC EDGAR's recent list, going back to Oct 10, 2003. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Vivani Medical, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Oct 30, 2026 Oct 30, 2026
8-K Current report
Regulation FD disclosure
Oct 29, 2026 Oct 29, 2026
424B5 Prospectus supplement Sep 25, 2026 —
8-K Current report
Regulation FD disclosure
Sep 16, 2026 Sep 16, 2026
8-K Current report
Regulation FD disclosure
Aug 17, 2026 Aug 17, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2026 Aug 13, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Aug 6, 2026 Aug 6, 2026
8-K Current report
Regulation FD disclosure
Jul 16, 2026 Jul 15, 2026
8-K Current report
Material agreement, Other events
Jul 7, 2026 Jul 1, 2026
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jun 30, 2026 Jun 24, 2026
8-K Current report
Regulation FD disclosure
Jun 4, 2026 Jun 4, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 13, 2026 May 13, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 29, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 26, 2026 Mar 26, 2026
10-K Annual report Mar 26, 2026 Dec 31, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 27, 2026 Jan 25, 2026
424B5 Prospectus supplement Jan 27, 2026 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2025 Nov 13, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 28, 2025 Oct 26, 2025
424B5 Prospectus supplement Oct 28, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Oct 3, 2025 Oct 3, 2025
8-K Current report
Other events
Sep 17, 2025 Sep 17, 2025
8-K Current report
Regulation FD disclosure
Sep 9, 2025 Sep 9, 2025
8-K Current report
Other events
Sep 4, 2025 Sep 4, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
Aug 13, 2025 Aug 11, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Aug 5, 2025 Aug 5, 2025
8-K Current report
Shareholder vote results
Jun 25, 2025 Jun 24, 2025
8-K Current report
Regulation FD disclosure
Jun 17, 2025 Jun 17, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 11, 2025 Jun 11, 2025
8-K Current report
Other events
May 29, 2025 May 29, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
May 13, 2025 May 12, 2025
DEFR14A Filing May 6, 2025 —
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 24, 2025
8-K Current report
Other events
Apr 15, 2025 Apr 12, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 31, 2025 Mar 31, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Mar 27, 2025 Mar 26, 2025
8-K Current report
Other events
Mar 26, 2025 Mar 26, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Mar 13, 2025 Mar 13, 2025
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2024 Nov 13, 2024
8-K Current report
Other events
Oct 22, 2024 Oct 22, 2024
8-K Current report
Other events
Sep 26, 2024 Sep 26, 2024
8-K Current report
Other events
Sep 23, 2024 Sep 23, 2024
8-K Current report
Other events
Sep 4, 2024 Sep 4, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2024 Aug 13, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Other events
Jul 11, 2024 Jul 11, 2024
8-K Current report
Shareholder vote results
Jun 28, 2024 Jun 28, 2024
8-K Current report
Other events
Jun 13, 2024 Jun 7, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 13, 2024 May 13, 2024
EFFECT Filing May 3, 2024 —
CORRESP Letter to the SEC May 2, 2024 —
S-3/A Filing May 2, 2024 —
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 27, 2024
UPLOAD Letter from the SEC Apr 29, 2024 —
8-K Current report
Material agreement
Apr 23, 2024 Apr 22, 2024
S-3 Shelf registration Apr 22, 2024 —
10-K Annual report Mar 26, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Mar 26, 2024 Mar 26, 2024
8-K Current report
Officer or director change
Mar 6, 2024 Mar 4, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Mar 5, 2024 Mar 1, 2024
424B5 Prospectus supplement Mar 5, 2024 —
8-K Current report
Regulation FD disclosure
Feb 28, 2024 Feb 28, 2024
8-K Current report
Other events
Jan 10, 2024 Jan 9, 2024
8-K Current report
Listing notice
Dec 27, 2023 Dec 26, 2023
8-K Current report
Officer or director change
Nov 24, 2023 Nov 20, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Regulation FD disclosure
Sep 18, 2023 Sep 15, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Aug 29, 2023 Aug 25, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jul 10, 2023 Jul 5, 2023
8-K Current report
Shareholder vote results
Jun 16, 2023 Jun 15, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 15, 2023 May 15, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
ARS/A Filing May 1, 2023 Dec 31, 2022
DEFR14A Filing May 1, 2023 —
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 —
PRE 14A Preliminary proxy statement Apr 19, 2023 Apr 18, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
8-K Current report
Material agreement, Regulation FD disclosure
Mar 21, 2023 Mar 19, 2023
8-K Current report
Regulation FD disclosure
Feb 17, 2023 Feb 16, 2023
8-K Current report
Regulation FD disclosure
Jan 6, 2023 Jan 6, 2023
8-K Current report
Other events
Dec 15, 2022 Dec 9, 2022
8-K Current report
Material agreement
Nov 28, 2022 Nov 28, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2022 Nov 14, 2022
8-K Current report
Regulation FD disclosure, Other events
Oct 17, 2022 Oct 17, 2022
8-K Current report
Regulation FD disclosure
Sep 23, 2022 Sep 23, 2022
25 Filing Sep 8, 2022 —
S-8 Employee stock plan registration Sep 2, 2022 —
8-K Current report
Material agreement, Acquisition or sale of assets, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Sep 2, 2022 Aug 30, 2022
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Aug 18, 2022 Aug 16, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Officer or director change
Aug 5, 2022 Aug 3, 2022
425 Filing Jul 29, 2022 —
8-K Current report
Shareholder vote results, Other events
Jul 29, 2022 Jul 27, 2022
DEFA14A Additional proxy material Jul 18, 2022 —
DEFA14A Additional proxy material Jul 18, 2022 —
425 Filing Jul 18, 2022 —
8-K Current report
Other events
Jul 18, 2022 Jul 14, 2022
DEFA14A Additional proxy material Jul 12, 2022 —
EFFECT Filing Jun 24, 2022 —
DEFM14A Filing Jun 24, 2022 —
424B3 Prospectus Jun 24, 2022 —
CORRESP Letter to the SEC Jun 22, 2022 —
425 8-k Jun 21, 2022 —
8-K Current report
Material agreement
Jun 21, 2022 Jun 15, 2022
S-4/A Form s-4/a Jun 16, 2022 —
8-K Current report
Officer or director change
Jun 16, 2022 Jun 13, 2022
425 Filing Jun 7, 2022 —
8-K Current report
Other events
Jun 7, 2022 Jun 7, 2022
UPLOAD Letter from the SEC May 23, 2022 —
10-Q Quarterly report May 16, 2022 Mar 31, 2022
S-4 Registration for a merger or exchange May 13, 2022 —
10-K/A Amended annual report May 2, 2022 Dec 31, 2021
10-K Annual report Mar 29, 2022 Dec 31, 2021
425 8-k Feb 8, 2022 —
8-K Current report
Material agreement, Regulation FD disclosure
Feb 8, 2022 Feb 4, 2022
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
8-K Current report
Other events
Aug 4, 2021 Jul 29, 2021
8-K Current report
Auditor change
Jul 2, 2021 Jul 1, 2021
8-K Current report
Material agreement, Other events
Jun 28, 2021 Jun 22, 2021
424B5 Prospectus supplement Jun 23, 2021 —
8-K Current report
Other events
Jun 23, 2021 Jun 22, 2021
424B5 Prospectus supplement Jun 22, 2021 —
8-K Current report
Other events
Jun 21, 2021 Jun 18, 2021
EFFECT Filing Jun 14, 2021 —
CORRESP Letter to the SEC Jun 11, 2021 —
UPLOAD Letter from the SEC Jun 10, 2021 —
S-3 Shelf registration Jun 8, 2021 —
8-K Current report
Other events
Jun 4, 2021 Jun 1, 2021
8-K Current report
Other events
Jun 3, 2021 Jun 1, 2021
8-K Current report
Shareholder vote results, Other events
Jun 1, 2021 May 28, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
DEF 14A Proxy statement Apr 30, 2021 May 28, 2021
424B3 Prospectus Apr 29, 2021 —
EFFECT Filing Apr 28, 2021 —
CORRESP Letter to the SEC Apr 27, 2021 —
10-K/A Amended annual report Apr 27, 2021 Dec 31, 2020
UPLOAD Letter from the SEC Apr 22, 2021 —
S-3 Shelf registration Apr 16, 2021 —
10-K/A Amended annual report Apr 14, 2021 Dec 31, 2020
8-K Current report
Other events
Apr 8, 2021 Apr 7, 2021
D Filing Apr 7, 2021 —
8-K Current report
Officer or director change, Other events
Apr 6, 2021 Apr 5, 2021
8-K Current report
Agreement ended, Other events
Apr 5, 2021 Apr 1, 2021
8-K Current report
Officer or director change, Other events
Apr 1, 2021 Mar 26, 2021
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Mar 26, 2021 Mar 23, 2021
8-K Current report
Regulation FD disclosure, Other events
Mar 24, 2021 Mar 24, 2021
DEFA14A Additional proxy material Mar 24, 2021 —
10-K Annual report Mar 16, 2021 Dec 31, 2020
8-K/A Amended current report
Other events
Mar 5, 2021 Feb 26, 2021
DEFA14A Additional proxy material Mar 5, 2021 —
8-K Current report
Other events
Mar 5, 2021 Feb 26, 2021
8-K Current report
Material agreement, Other events
Jan 27, 2021 Jan 22, 2021
8-K Current report
Material agreement, Listing notice, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
Jan 6, 2021 Jan 5, 2021
DEFA14A Additional proxy material Jan 6, 2021 —
8-K Current report
Other events
Dec 16, 2020 Dec 15, 2020
8-K Current report
Material agreement
Dec 11, 2020 Dec 8, 2020
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
8-K Current report
Listing notice
Oct 2, 2020 Oct 2, 2020
8-K Current report
Officer or director change
Sep 29, 2020 Sep 27, 2020
8-K Current report
Other events
Sep 25, 2020 Sep 22, 2020
8-K Current report
Officer or director change
Sep 4, 2020 Aug 31, 2020
10-Q Quarterly report Aug 13, 2020 Jun 30, 2020
8-K Current report
Listing notice
Jul 27, 2020 Jul 23, 2020
8-K Current report
Listing notice
Jul 22, 2020 Jul 21, 2020
8-K Current report
Listing notice
Jul 21, 2020 Jul 15, 2020
8-K Current report
Material agreement
Jul 10, 2020 Jul 7, 2020
8-K Current report
Other events
Jul 1, 2020 Jun 25, 2020
10-Q Quarterly report Jun 26, 2020 Mar 31, 2020
8-K Current report
Listing notice
Jun 4, 2020 Jun 1, 2020
8-K Current report
Officer or director change
May 28, 2020 May 27, 2020
8-K Current report
Agreement ended
May 21, 2020 May 18, 2020
8-K Current report
Officer or director change
May 19, 2020 May 13, 2020
8-K Current report
Officer or director change, Other events
May 12, 2020 May 8, 2020
8-K Current report
Material agreement
May 6, 2020 Apr 30, 2020
8-K Current report
Other events
May 5, 2020 May 5, 2020
424B5 Prospectus supplement May 1, 2020 —
8-K Current report
Other events
May 1, 2020 Apr 30, 2020
FWP Free writing prospectus Apr 29, 2020 —
424B5 Prospectus supplement Apr 29, 2020 —
8-K Current report
Other events
Apr 28, 2020 Apr 28, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
VANI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Alameda, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1266806
Former names
SECOND SIGHT MEDICAL PRODUCTS INC (until Aug 18, 2022); SECOUND SIGHT MEDICAL PRODUCTS INC (until Oct 10, 2003)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.